ASO Visual Abstract: Optimizing Circulating Tumor DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma—Diagnosis, Screening, Minimal Residual Disease Detection, and Treatment Response Monitoring

被引：0
|
作者：
Woo Jin Choi
Tommy Ivanics
Annabel Gravely
Steven Gallinger
Gonzalo Sapisochin
Grainne M. O’Kane
机构：
[1] University of Toronto,Department of Surgery
[2] University of Toronto,Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health
[3] University of Toronto Staff Surgeon,Division of General Surgery
[4] HBP and Multi Organ Transplant Program,Department of Surgery
[5] University Health Network,Department of Surgical Sciences
[6] Henry Ford Hospital,Department of Medical Oncology, Trinity St. James’s Cancer Institute
[7] Uppsala University,undefined
[8] Trinity College Dublin,undefined
[9] St. James’s Hospital,undefined
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3866 / 3867
页数：1
相关论文
共 22 条
  • [1] ASO Visual Abstract: Optimizing Circulating Tumor DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma-Diagnosis, Screening, Minimal Residual Disease Detection, and Treatment Response Monitoring
    Choi, Woo Jin
    Ivanics, Tommy
    Gravely, Annabel
    Gallinger, Steven
    Sapisochin, Gonzalo
    O'Kane, Grainne M.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (06) : 3866 - 3867
  • [2] Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring
    Choi, Woo Jin
    Ivanics, Tommy
    Gravely, Annabel
    Gallinger, Steven
    Sapisochin, Gonzalo
    O'Kane, Grainne M.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (06) : 3849 - 3863
  • [3] Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring
    Woo Jin Choi
    Tommy Ivanics
    Annabel Gravely
    Steven Gallinger
    Gonzalo Sapisochin
    Grainne M. O’Kane
    Annals of Surgical Oncology, 2023, 30 : 3849 - 3863
  • [4] ASO Visual Abstract: Tumor Burden Monitoring with Circulating Tumor DNA During Treatment in Patients with Esophageal Squamous Cell Carcinoma
    Morimoto, Yosuke
    Matsuda, Satoru
    Kawakubo, Hirofumi
    Nakamura, Kohei
    Kobayashi, Ryota
    Hisaoka, Kazuhiko
    Okui, Jun
    Takeuchi, Masashi
    Aimono, Eriko
    Fukuda, Kazumasa
    Nakamura, Rieko
    Saya, Hideyuki
    Nishihara, Hiroshi
    Kitagawa, Yuko
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (06) : 3759 - 3759
  • [5] Circulating tumor cells as a biomarker for monitoring: Disease progression, treatment response, and minimal residual disease.
    Raut, Nirmal Vivek
    Bharde, Atul
    Gourishankar, Aland
    Jayant, Sreeja
    Garbhe, Meghana
    Gosavi, Sayali
    Janorkar, Apoorva
    D'Souza, Alain
    Vasudevan, Aravindan
    Khandare, Jayant
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Tumor-related alterations in circulating DNA, potential for diagnosis, prognosis and detection of minimal residual disease
    P Anker
    M Stroun
    Leukemia, 2001, 15 : 289 - 291
  • [7] Tumor-related alterations in circulating DNA, potential for diagnosis, prognosis and detection of minimal residual disease
    Anker, P
    Stroun, M
    LEUKEMIA, 2001, 15 (02) : 289 - 291
  • [8] Circulating Tumor DNA for Monitoring Minimal Residual Disease and Early Detection of Recurrence in Early Stage Lung Cancer
    Tan, A.
    Lai, G.
    Saw, S.
    Chua, K.
    Takano, A.
    Ong, B.
    Koh, T.
    Jain, A.
    Tan, W.
    Ng, Q.
    Kanesvaran, R.
    Rajasekaran, T.
    Kalshnikova, E.
    Shchegrova, S.
    Ta, H.
    Lin, J.
    Renner, D.
    Sethi, H.
    Zimmermann, B.
    Aleshin, A.
    Lim, W.
    Tan, E.
    Skanderup, A.
    Ang, M.
    Tan, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S907 - S907
  • [9] Non-Invasive Monitoring of Urinary KRAS Circulating Tumor DNA for Treatment Response and Minimal Residual Disease in Patients with Lung Adenocarcinoma.
    Randall, James Michael
    Erlander, Mark G.
    Vibat, Cecile Rose T.
    Hancock, Saege
    Melnikova, Vlada
    Cohen, Ezra E. W.
    Lippman, Scott Michael
    Kurzrock, Razelle
    Husain, Hatim
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients
    Eroglu, Zeynep
    Krinshpun, Shifra
    Kalashnikova, Ekaterina
    Sudhaman, Sumedha
    Topcu, Turkan Ozturk
    Nichols, Matt
    Martin, Justin
    Bui, Katherine M.
    Palsuledesai, Charuta C.
    Malhotra, Meenakshi
    Olshan, Perry
    Markowitz, Joseph
    Khushalani, Nikhil I.
    Tarhini, Ahmad A.
    Messina, Jane L.
    Aleshin, Alexey
    CANCER, 2023, 129 (11) : 1723 - 1734
123